Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease
03 oct. 2024 16h01 HE
|
Abivax
Abivax Announces First Patient Enrolled in ENHANCE-CD, the Phase 2b Trial of Obefazimod in Crohn’s Disease PARIS, France, October 3, 2024 – 10:00 p.m. CEST – Abivax SA (Euronext Paris:...
Blue Mountain and Apprentice.io Announce Groundbreaking Integration of EAM and MES Technologies, Transforming Asset Performance Management for Life Sciences Manufacturing
03 oct. 2024 09h00 HE
|
Blue Mountain; Apprentice.io
Blue Mountain & Apprentice.io announce groundbreaking integration of EAM & MES technologies for life sciences manufacturers.
CytoMed Therapeutics completes cash acquisition of Cord Blood Banking Licence and Assets expanding CytoMed’s strategy to cord blood-derived biologics through subsidiary, LongevityBank
03 oct. 2024 07h00 HE
|
CYTOMED THERAPEUTICS LIMITED
SINGAPORE, Oct. 03, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary...
Kurma Partners achieves first close of new EUR 250 million Biofund IV
03 oct. 2024 03h00 HE
|
Kurma Partners
Biofund IV raised EUR 140 million in first closing of EUR 250 million fundBiofund IV to follow Kurma’s proven investment strategy and make 16 to 20 new investmentsFirst three investments of the new...
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®
03 oct. 2024 03h00 HE
|
Enara bio
New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio’s EDAPT®...
Results from a Phase I clinical trial of a dendritic cell targeting prophylactic HIV vaccine published in the Journal eClinical Medicine
02 oct. 2024 10h24 HE
|
EnnoDC
PRESS RELEASE Results from a Phase I clinical trial of a dendritic cell targeting prophylactic HIV vaccine published in the Journal eClinical Medicine Provides important validation of the safety...
PharmAla to supply Harvard Medical School’s Maclean Hospital with LaNeo MDMA
02 oct. 2024 09h20 HE
|
PharmAla Biotech
PharmAla Biotech signs contract to supply Harvard neuropsychiatry hospital with MDMA; Appears at CPHI Conference in Milan
aTyr Pharma Announces Publication Demonstrating Efficacy of Efzofitimod in Pulmonary Sarcoidosis in the European Respiratory Journal
02 oct. 2024 08h00 HE
|
aTyr Pharma, Inc.
aTyr Pharma Announces Publication Demonstrating Efficacy of Efzofitimod in Pulmonary Sarcoidosis in the European Respiratory Journal
Madrigal Pharmaceuticals to Participate in the H.C. Wainwright & Co. 8th Annual MASH Investor Conference
02 oct. 2024 08h00 HE
|
Madrigal Pharmaceuticals, Inc.
CONSHOHOCKEN, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced the company will participate in a fireside chat at the H.C. Wainwright 8th Annual...
Big4Bio Names David J. Whelan Its New Chief Business Officer
02 oct. 2024 07h30 HE
|
BigBio Communications
SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- BigBio Communications is excited to announce that it is expanding the Big4Bio leadership team with the appointment of David J. Whelan as Chief...